Biomedical Engineering Reference
In-Depth Information
Miller, M.A and F.P. Cappuccio. 2007a. Ethnicity and inl ammatory pathways - implications
for vascular disease, vascular risk and therapeutic intervention. Curr. Med. Chem. 14:
1409-1425.
Miller, M.A. and F.P. Cappuccio. 2007b. Inl ammation, sleep, obesity and cardiovascular
disease. Curr. Vasc. Pharmacol. 5: 93-102.
Miller, M.A. and S.M. Kerry, D.G. Cook, and F.P. Cappuccio. 2004. Cellular adhesion
molecules and blood pressure: interaction with sex in a multi-ethnic population. J.
Hypertens. 22: 705-711.
Pigott, R. and L.P. Dillon, I.H. Hemingway, and A.J. Gearing. 1992. Soluble forms of
E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated
cultured endothelial cells. Biochem. Biophys. Res. Commun. 187: 584-589.
Ponthieux, A. and B. Herbeth, S. Droesch, N. Haddy, D. Lambert, and S. Visvikis. 2004.
Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels
in healthy subjects: the Stanislas study. Atherosclerosis 172: 299-308.
Pontiroli, A.E. and F. Frigè, M. Paganelli, and F. Folli. 2008. In Morbid obesity, metabolic
abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous
fat: ef ect of weight loss through surgery. Obes. Surg. Jul. 16 [Epub ahead of print].
Rohde, L.E. and C.H. Hennekens, and P.M. Ridker. 1999. Cross-sectional study of soluble
intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy
men. Arterioscler. h romb. Vasc. Biol. 19: 1595-1599.
Sanada, H. and S. Midorikawa, J. Yatabe, M.S. Yatabe, T. Katoh, T. Baba, S. Hashimoto,
and T. Watanabe. 2005. Elevation of serum soluble E- and P-selectin in patients
with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
Hypertens. Res. 28: 871-878.
Shai, I. and T. Pischon, F.B. Hu, A. Ascherio, N. Rifai, and E.B. Rimm. 2006. Soluble
intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of
coronary heart disease. Obesity (Silver Spring) 14: 2099-2106.
Soro-Paavonen, A. and J. Westerbacka, C. Ehnholm, and M.R. Taskinen. 2006. Metabolic
syndrome aggravates the increased endothelial activation and low-grade inl ammation
in subjects with familial low HDL. Ann. Med. 38: 229-238.
Tsiara, S. and M. Elisaf, and D.P. Mikhailidis. 2003. Early vascular benei ts of statin therapy.
Curr. Med. Res. Opin. 19: 540-556.
Software
Poser 7 (c). 1991-2008. Smith Micro Sot ware, Inc., California, USA.
